Business Wire

DILIGENT

Del
Diligent Announces Reaching 400 Clients in the EMEA Region

Diligent (NZX:DIL ), provider of the Diligent Boardbooks ® solution – the world’s most widely-used board portal – today announced that more than 400 companies across Europe, Middle East and Africa now use its solution to produce, distribute and communicate confidential company information to their boards, management teams and committees. Included in this total are 100 FTSE 350 companies in the UK and more than 50 percent of AEX Index companies in the Netherlands. From the smallest charities to the largest listed companies, organizations are making the transition from traditional, paper-based board packs, to using Diligent’s secure, digital board portal.

One of Diligent’s customers is Randstad Holding, the second-largest HR services company in the world. The company, which is headquartered in Diemen, Netherlands, provides work for more than half a million people around the world each day. Its executive board meets every two weeks while the supervisory group convenes seven to eight times a year. Jelle Miedema, Company Secretary for Randstad, said: “Adopting the Diligent approach puts your mind at ease. For everything from the ability to archive thousands of pages of reports and have them at your fingertips, to knowing you have secure, up-to-date information powering better decisions.”

Another Diligent customer, Intu Properties, is a major FTSE 100 property company with assets of £8.8 billion. The company owns and operates shopping centres in prime locations across the UK, including 10 of the country’s top 25 centres. Intu Properties has a main board and four board committees, with a total of 25 different board and committee members. Susan Marsden, Intu Properties’ Company Secretary, estimates that the company has saved 50 percent of time in the production of board materials by using the Diligent Boardbooks solution. She said: “We even use the app to distribute press cuttings, update calendars and send secure documentation.”

Diligent is committed to, and investing in, the growth of its EMEA market. In July 2014, the company invested more than €1.7 million to offer clients data hosting in Frankfurt, Germany, with a data disaster recovery site in Düsseldorf.

“Information security is paramount for all companies, no matter how big or small, which is one of the main reasons they choose to use the Diligent Boardbooks solution,” said Charlie Horrell, Managing Director, Europe, Middle East and Africa at Diligent. “A board portal is a much safer way of distributing information than using paper or email, as well as being far more efficient in terms of time and resource. It means the company retains control of how the information is accessed and treated.”

About Diligent

Over 87,000 individual directors, executives and board teams worldwide rely on Diligent (NZX:DIL) to speed and simplify how board materials are produced, delivered, reviewed and voted on. Providing the world's most widely used board portal via iPad, Windows devices and browsers, Diligent has pioneered ease of use, stringent security, and superior training and support since 2001. The Diligent Boardbooks solution provides directors and management with immediate access to their most time-sensitive and confidential information along with the tools to review, discuss and collaborate on it. It also helps administrative staff accelerate production and delivery, and corporate executives streamline board communications and decisions. For more information, visit www.boardbooks.com .

Safe Harbor Statement

Statements made in this press release that state Diligent Board Member Services, Inc.’s or management's intentions, beliefs, expectations, or predictions for the future are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Readers are cautioned that these statements are only predictions and may differ materially from actual future events or results. All forward-looking statements are only as of the date of this press release and Diligent Board Member Services, Inc. undertakes no obligation to update or revise them. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause Diligent Board Member Services, Inc.’s actual results to differ materially from those projected in such forward-looking statements. For example, if we do not successfully develop or introduce new product offerings, or enhancements to our existing Diligent Boardbooks offerings, or keep pace with technological changes that impact the use of our product offerings, or suffer security breaches or service delays or interruptions, we may lose existing customers or fail to attract new customers and our financial performance and revenue growth may suffer. Factors which could cause our actual results to differ materially from those projected in forward-looking statements include, without limitation, economic, competitive, regulatory and technological factors affecting Diligent Board Member Services, Inc.’s operations, markets, products, services, and other factors set forth in Diligent Board Member Services, Inc.’s updated Risk Factors filed as Item 1A to its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2014 for further information.

Contact:

Carrot Communications
Media Contacts:
Kate Hartley, 0203 178 5052
or
Malini Majithia, 0771 406 5233
diligent@carrotcomms.co.uk

Twitter: @carrotcomms

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 14:00:00 CEST | Press release

BRUKINSA plus venetoclax demonstrated high response rates and a favorable safety profile across CLL patient types in SEQUOIA Arm D, including those with high-risk del(17p) mutational statusAt 5-year follow-up of SEQUOIA Arm C, BRUKINSA monotherapy showed sustained OS and PFS benefit in hard-to-treat del(17p) CLL patients versus historical data BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall dee

Andersen Consulting tilføjer Stratence Partners30.5.2025 16:07:00 CEST | Pressemeddelelse

Andersen Consulting udvider sin platform med en samarbejdsaftale med Stratence Partners, der er et konsulentfirma med base i Storbritannien, som hjælper globale virksomheder med at øge markedsandele og forbedre rentabiliteten gennem deres ekspertise inden for prisfastsættelse, strategisk optimering, kommerciel effektivitet og digital transformation. Stratence Partners har en resultatorienteret tilgang og er forpligtet på bæredygtig forandring, hvorved de hjælper deres kunder gennem en unik kombination af konsulentbistand, midlertidige ledelsesindsater og oplæringskurser samt deres egne metoder og løsninger inden for datastyring, datavidenskab (AI), værktøjer og systemer. "Samarbejdet med Andersen Consulting er et spændende skridt for vores firma," sagde Fernando Ventureira, administrerende direktør for Stratence Partners. "I vores arbejde med hos ledere over hele verden har vi erfaret, at deres behov rækker ud over strategisk prisfastsættelse og driftsoptimering. Vores kunder værdsætte

You Up? Grindr’s “Right Now” Goes Global30.5.2025 15:00:00 CEST | Press release

More places, more people – Grindr’s real-time hookup feature makes connecting faster than ever Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded

CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 14:00:00 CEST | Press release

Only approximately 2 out of 10 people in the US and 3 out of 10 people in Europe with certain rare, advanced blood cancers receive access to CAR T-cell therapy1,2,3New roadmap report aims to inspire collective action of stakeholder groups and invites additional CAR T-cell therapy leaders to join the coalition Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative fin

Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 11:17:00 CEST | Press release

In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye